CellScape Receives $1,586,785 New Funding Round

  • Feed Type
  • Date
    1/4/2011
  • Company Name
    CellScape
  • Mailing Address
    465 Fairchild Dr., Building A Mountain View, CA 94043
  • Company Description
    The company is developing technology to enable noninvasive, fetal genetic testing in the period between the eight weeks and 14 weeks of pregnancy.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,586,785
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed